欧洲 · 通讯社与实时数据 · Reuters US Markets

Swiss drug developer Windward Bio files for US IPO

来源：Reuters US Markets · 英国 9 小时前

Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed ‌investor interest in biotech listings.

在 Reuters US Markets 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)

Swiss drug developer Windward Bio files for US IPO

推荐阅读

Saudi Arabia not to host Intervision this year — TASS source

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

What is going on with SpaceX's Starlink and Starshield in Ukraine?

Ready for a French test?: Five questions for the ECB

Swiss drug developer Windward Bio files for US IPO

分享

推荐阅读

Saudi Arabia not to host Intervision this year — TASS source

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

What is going on with SpaceX's Starlink and Starshield in Ukraine?

Ready for a French test?: Five questions for the ECB